Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

Meng, Juan; Xiao, Guohui; Zhang, Juanjuan; He, Xing; Ou, Min; Bi, Jing; Yang, Rongqing; Di, Wencheng; Wang, Zhaoqin; Li, Zigang; Gao, Hong; Liu, Lei; Zhang, Guoliang

doi:10.1080/22221751.2020.1746200

Public

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

Published in Emerging Microbes & Infections • Jan 1, 2020

Authors:

Juan Meng

Guohui Xiao

Juanjuan Zhang

Abstract

The dysfunction of the renin-angiotensin system (RAS) has been observed in coronavirus infection disease (COVID-19) patients, but whether RAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs), are associated with clinical outcomes...

Subject

Medicine

Renin–angiotensin system

Coronavirus disease 2019 (COVID-19)

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!